UNIGE document Scientific Article
previous document  unige:149077  next document
add to browser collection

Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease

Katsyuba, Elena
Lindenmeyer, Maja
Naesens, Maarten
Mottis, Adrienne
show hidden authors show all authors [1 - 17]
Published in Nephrology Dialysis Transplantation. 2021, vol. 36, no. 1, p. 60-68
Abstract Background: Nicotinamide adenine dinucleotide (NAD+) is a ubiquitous coenzyme involved in electron transport and a co-substrate for sirtuin function. NAD+ deficiency has been demonstrated in the context of acute kidney injury (AKI). Methods: We studied the expression of key NAD+ biosynthesis enzymes in kidney biopsies from human allograft patients and patients with chronic kidney disease (CKD) at different stages. We used ischaemia-reperfusion injury (IRI) and cisplatin injection to model AKI, urinary tract obstruction [unilateral ureteral obstruction (UUO)] and tubulointerstitial fibrosis induced by proteinuria to investigate CKD in mice. We assessed the effect of nicotinamide riboside (NR) supplementation on AKI and CKD in animal models. Results: RNA sequencing analysis of human kidney allograft biopsies during the reperfusion phase showed that the NAD+de novo synthesis is impaired in the immediate post-transplantation period, whereas the salvage pathway is stimulated. This decrease in de novo NAD+ synthesis was confirmed in two mouse models of IRI where NR supplementation prevented plasma urea and creatinine elevation and tubular injury. In human biopsies from CKD patients, the NAD+de novo synthesis pathway was impaired according to CKD stage, with better preservation of the salvage pathway. Similar alterations in gene expression were observed in mice with UUO or chronic proteinuric glomerular disease. NR supplementation did not prevent CKD progression, in contrast to its efficacy in AKI. Conclusion: Impairment of NAD+ synthesis is a hallmark of AKI and CKD. NR supplementation is beneficial in ischaemic AKI but not in CKD models.
PMID: 33099633
Full text
Article (Published version) (841 Kb) - public document Free access
Supplemental data (1.4 MB) - public document Free access
Other version: https://academic.oup.com/ndt/article/36/1/60/5939791
Research groups Insuffisance rénale chronique (941)
Laboratoire de physiologie et pathophysiologie des cellules rénales (29)
Swiss National Science Foundation: PP00P3_187186
Swiss National Science Foundation: 323530_191224
(ISO format)
FAIVRE, Anna et al. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease. In: Nephrology Dialysis Transplantation, 2021, vol. 36, n° 1, p. 60-68. doi: 10.1093/ndt/gfaa124 https://archive-ouverte.unige.ch/unige:149077

264 hits



Deposited on : 2021-02-12

Export document
Format :
Citation style :